Monthly Archives: April 2012

Government ‘politicising’ PBS process Health groups say cancer patients and people with schizophrenia are among those who will be affected by the Federal Government’s decision to delay subsidising some medicines. The Government has delayed putting several medicines on the Pharmaceutical … Continue reading →

UPDATE 1-Par Pharmaceutical settles drug pricing lawsuits Says settlement will remove major damages and trials (Follows alerts) (Reuters) – Par Pharmaceutical Cos Inc said it settled drug pricing lawsuits against it that allegedly caused government entities to pay inflated reimbursements … Continue reading →

The Rise Of The Pharmaceutical Un-Sales Force In a variation on the old saying “if you can’t beat ‘em, join ‘em,” a number of states have initiated programs where purportedly independent clinicians, pharmacists and other medical personnel pay visits to … Continue reading →

FDA approves Taro’s Canadian pharmaceutical facility Taro Pharmaceutical Industries Ltd. (Pink Sheets: TAROF) can resume regular production at its Canadian manufacturing facility, after the US Food and Drug Administration (FDA) approved the facility, following a re inspection of the site … Continue reading →

Bayer Responds to Studies Linking Birth Control Pills to Blood Clots Following two studies that claim hormones used in newer birth control pills could put women at a greater risk of developing blood clots, Bayer HealthCare Pharmaceuticals, Inc. — who … Continue reading →

Cumberland Pharmaceuticals acquires drug candidate from Vanderbilt Cumberland Pharmaceuticals Inc. said Tuesday it has agreed to acquire rights to a molecule named ifetroban that it plans to test as a potential in-hospital treatment for a condition that involves progressive kidney … Continue reading →

Legal Help for Mothers Who Took Antiepileptic Meds During Pregnancy Taking antiepileptic or anticonvulsant medication such Depakote or Depakene to treat epilepsy, bipolar episodes of manic depression, and migraine headaches, during pregnancy may lead to birth defects. (PRWEB) April 20, … Continue reading →

Kansas launches pharmacy tracking system TOPEKA | Kansas officials on Monday launched a new, electronic system designed to better track the sale of pharmaceuticals used in making methamphetamine. Attorney General Derek Schmidt and representatives of the Board of Pharmacy said … Continue reading →

Research and Markets: Exit Strategy Options for Biotech & Pharmaceutical Companies in 2011-2012 In “Exit Strategy Options for Biotech & Pharmaceutical Companies in 2011-2012″, ExecSense examines what CEOs, CFOs (and their management teams) need to know about why the next … Continue reading →

Beacon Enterprise Solutions Group adds pharmaceutical client Beacon Enterprise Solutions Group Inc. has signed a third U.S.-based Fortune 500 pharmaceutical client, according to a company news release. Terms of the deal and the name of the client were not disclosed. … Continue reading →